Cargando…
Changes in radiotherapy fractionation—breast cancer
Conventional fractionation for half a century has been justified on the basis that 2.0 Gy fractions spare dose-limiting late-responding normal tissues to a greater degree than cancerous tissues. Early indications that breast cancer responds more strongly to fraction size than many other common cance...
Autor principal: | Yarnold, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330077/ https://www.ncbi.nlm.nih.gov/pubmed/29345152 http://dx.doi.org/10.1259/bjr.20170849 |
Ejemplares similares
-
The tumour microenvironment links complement system dysregulation and hypoxic signalling
por: Olcina, Monica M, et al.
Publicado: (2019) -
Clinical trials targeting hypoxia
por: Tharmalingham, Hannah, et al.
Publicado: (2019) -
The Biological Basis for Enhanced Effects of Proton Radiation Therapy Relative to Photon Radiation Therapy for Head and Neck Squamous Cell Carcinoma
por: Wang, Li, et al.
Publicado: (2021) -
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice
por: Barra, Salvina, et al.
Publicado: (2020) -
Data-driven Markov models and their application in the evaluation of adverse events in radiotherapy
por: Abler, Daniel, et al.
Publicado: (2013)